This study is looking at the safety and whether it's possible to perform a procedure called corneal cross-linking on both eyes on the same day for people with keratoconus. Keratoconus is an eye condition that causes the cornea (the clear front part of your eye) to thin and bulge. The procedure uses Riboflavin Ophthalmic Solutions (eye drops) and a UV-A Irradiation System (a special light) to strengthen the cornea. The main goal is to see if this same-day treatment can be successfully completed in both eyes. You may be able to join if you are 13 years or older, have keratoconus in both eyes, and can follow study instructions. We are looking to enroll 15 participants, but the current recruitment status is unclear.

Study design

This is an interventional study, meaning participants will receive a specific treatment. It aims to enroll 15 participants.

What's involved

You would need to provide written informed consent and be willing and able to comply with study instructions and follow-up visits.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at approximately 2.5 months, indicating follow-up for at least that duration.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.